Abecma (idecabtagene vicleucel)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Abecma (idecabtagene vicleucel), covering 2026-03-05 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation [Phase 3]